Preliminary studies indicate conolidine may inhibit specific ion channels, lessening neuronal excitability and limiting ache signals. This mechanism is especially applicable in neuropathic discomfort, in which abnormal signaling brings about persistent irritation. Furthermore, conolidine seems to affect G protein-coupled receptor (GPCR) pathways in